| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alpha-amylase activity | 9.95e-08 | 5 | 44 | 3 | GO:0004556 | |
| GeneOntologyMolecularFunction | amylase activity | 1.99e-07 | 6 | 44 | 3 | GO:0016160 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 3.07e-06 | 103 | 44 | 5 | GO:0004553 | |
| GeneOntologyMolecularFunction | chloride ion binding | 5.48e-06 | 16 | 44 | 3 | GO:0031404 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 1.58e-05 | 144 | 44 | 5 | GO:0016798 | |
| GeneOntologyMolecularFunction | complement component C3b binding | 3.09e-04 | 12 | 44 | 2 | GO:0001851 | |
| GeneOntologyMolecularFunction | antigen binding | 8.01e-04 | 190 | 44 | 4 | GO:0003823 | |
| GeneOntologyMolecularFunction | calcium ion binding | 1.16e-03 | 749 | 44 | 7 | GO:0005509 | |
| GeneOntologyMolecularFunction | sialic acid binding | 1.38e-03 | 25 | 44 | 2 | GO:0033691 | |
| GeneOntologyMolecularFunction | opsonin binding | 1.38e-03 | 25 | 44 | 2 | GO:0001846 | |
| GeneOntologyMolecularFunction | complement binding | 2.26e-03 | 32 | 44 | 2 | GO:0001848 | |
| GeneOntologyMolecularFunction | peptidase activity | 2.95e-03 | 654 | 44 | 6 | GO:0008233 | |
| GeneOntologyBiologicalProcess | immunoglobulin production | 1.16e-05 | 241 | 44 | 6 | GO:0002377 | |
| GeneOntologyCellularComponent | immunoglobulin complex | 3.86e-05 | 166 | 48 | 5 | GO:0019814 | |
| Domain | Sushi | 5.01e-06 | 52 | 41 | 4 | PF00084 | |
| Domain | CCP | 5.84e-06 | 54 | 41 | 4 | SM00032 | |
| Domain | SUSHI | 6.76e-06 | 56 | 41 | 4 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 7.26e-06 | 57 | 41 | 4 | IPR000436 | |
| Domain | Ago_hook | 1.41e-05 | 3 | 41 | 2 | PF10427 | |
| Domain | TNRC6_PABC-bd | 1.41e-05 | 3 | 41 | 2 | IPR032226 | |
| Domain | Argonaute_hook_dom | 1.41e-05 | 3 | 41 | 2 | IPR019486 | |
| Domain | TNRC6-PABC_bdg | 1.41e-05 | 3 | 41 | 2 | PF16608 | |
| Domain | EGF-like_dom | 1.61e-05 | 249 | 41 | 6 | IPR000742 | |
| Domain | EGF_2 | 2.29e-05 | 265 | 41 | 6 | PS01186 | |
| Domain | Aamy_C | 2.81e-05 | 4 | 41 | 2 | SM00632 | |
| Domain | Alpha_amylase | 2.81e-05 | 4 | 41 | 2 | IPR006046 | |
| Domain | Alpha-amylase_C | 4.68e-05 | 5 | 41 | 2 | PF02806 | |
| Domain | A-amylase/branching_C | 4.68e-05 | 5 | 41 | 2 | IPR006048 | |
| Domain | GPS | 5.60e-05 | 34 | 41 | 3 | SM00303 | |
| Domain | GPCR_2_secretin-like_CS | 5.60e-05 | 34 | 41 | 3 | IPR017983 | |
| Domain | GPS | 6.12e-05 | 35 | 41 | 3 | PF01825 | |
| Domain | GPS | 6.67e-05 | 36 | 41 | 3 | PS50221 | |
| Domain | GPS | 7.24e-05 | 37 | 41 | 3 | IPR000203 | |
| Domain | Aamy | 9.81e-05 | 7 | 41 | 2 | SM00642 | |
| Domain | Glyco_hydro_13_cat_dom | 9.81e-05 | 7 | 41 | 2 | IPR006047 | |
| Domain | Alpha-amylase | 9.81e-05 | 7 | 41 | 2 | PF00128 | |
| Domain | EGF_3 | 1.57e-04 | 235 | 41 | 5 | PS50026 | |
| Domain | EGF | 1.57e-04 | 235 | 41 | 5 | SM00181 | |
| Domain | DUF1220 | 1.68e-04 | 9 | 41 | 2 | SM01148 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 1.79e-04 | 50 | 41 | 3 | PS00650 | |
| Domain | 7tm_2 | 1.79e-04 | 50 | 41 | 3 | PF00002 | |
| Domain | Glycoside_hydrolase_SF | 2.13e-04 | 53 | 41 | 3 | IPR017853 | |
| Domain | EGF_1 | 2.29e-04 | 255 | 41 | 5 | PS00022 | |
| Domain | EGF-like_CS | 2.55e-04 | 261 | 41 | 5 | IPR013032 | |
| Domain | NBPF_dom | 2.55e-04 | 11 | 41 | 2 | IPR010630 | |
| Domain | NBPF | 2.55e-04 | 11 | 41 | 2 | PS51316 | |
| Domain | DUF1220 | 2.55e-04 | 11 | 41 | 2 | PF06758 | |
| Domain | TIL | 3.06e-04 | 12 | 41 | 2 | PF01826 | |
| Domain | C8 | 3.06e-04 | 12 | 41 | 2 | PF08742 | |
| Domain | GPCR_2_secretin-like | 3.08e-04 | 60 | 41 | 3 | IPR000832 | |
| Domain | GPCR_2-like | 3.08e-04 | 60 | 41 | 3 | IPR017981 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 3.23e-04 | 61 | 41 | 3 | PS50261 | |
| Domain | Unchr_dom_Cys-rich | 3.61e-04 | 13 | 41 | 2 | IPR014853 | |
| Domain | C8 | 3.61e-04 | 13 | 41 | 2 | SM00832 | |
| Domain | TIL_dom | 4.21e-04 | 14 | 41 | 2 | IPR002919 | |
| Domain | Glyco_hydro_b | 4.85e-04 | 15 | 41 | 2 | IPR013780 | |
| Domain | VWD | 5.53e-04 | 16 | 41 | 2 | SM00216 | |
| Domain | VWF_type-D | 5.53e-04 | 16 | 41 | 2 | IPR001846 | |
| Domain | VWFD | 5.53e-04 | 16 | 41 | 2 | PS51233 | |
| Domain | VWD | 5.53e-04 | 16 | 41 | 2 | PF00094 | |
| Domain | VWC_out | 7.85e-04 | 19 | 41 | 2 | SM00215 | |
| Domain | EGF | 2.65e-03 | 126 | 41 | 3 | PF00008 | |
| Domain | VWC | 3.14e-03 | 38 | 41 | 2 | SM00214 | |
| Domain | Glyco_hydro_catalytic_dom | 3.14e-03 | 38 | 41 | 2 | IPR013781 | |
| Domain | VWFC_2 | 3.14e-03 | 38 | 41 | 2 | PS50184 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 3.48e-03 | 40 | 41 | 2 | PS00649 | |
| Domain | GPCR_2_extracellular_dom | 3.48e-03 | 40 | 41 | 2 | IPR001879 | |
| Domain | LDLR_class-A_CS | 3.48e-03 | 40 | 41 | 2 | IPR023415 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 3.48e-03 | 40 | 41 | 2 | PS50227 | |
| Domain | VWF_dom | 3.83e-03 | 42 | 41 | 2 | IPR001007 | |
| Domain | Ldl_recept_a | 4.38e-03 | 45 | 41 | 2 | PF00057 | |
| Domain | - | 4.58e-03 | 46 | 41 | 2 | 4.10.400.10 | |
| Domain | LDLRA_1 | 4.98e-03 | 48 | 41 | 2 | PS01209 | |
| Domain | LDLRA_2 | 5.18e-03 | 49 | 41 | 2 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 5.18e-03 | 49 | 41 | 2 | IPR002172 | |
| Domain | LDLa | 5.18e-03 | 49 | 41 | 2 | SM00192 | |
| Domain | TSP_1 | 8.44e-03 | 63 | 41 | 2 | PF00090 | |
| Domain | UBA-like | 8.70e-03 | 64 | 41 | 2 | IPR009060 | |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 8.97e-09 | 115 | 34 | 7 | M19752 | |
| Pathway | REACTOME_CD22_MEDIATED_BCR_REGULATION | 3.24e-07 | 61 | 34 | 5 | M27581 | |
| Pathway | REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS | 6.98e-07 | 71 | 34 | 5 | M1078 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION_AMYLASE_ | 1.07e-06 | 9 | 34 | 3 | M47622 | |
| Pathway | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | 1.27e-06 | 80 | 34 | 5 | M6121 | |
| Pathway | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | 1.82e-06 | 86 | 34 | 5 | M601 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 2.09e-06 | 11 | 34 | 3 | M1091 | |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 3.47e-06 | 98 | 34 | 5 | M27152 | |
| Pathway | REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION | 1.61e-05 | 134 | 34 | 5 | M29840 | |
| Pathway | REACTOME_FCGR_ACTIVATION | 2.18e-05 | 69 | 34 | 4 | M27108 | |
| Pathway | REACTOME_SCAVENGING_OF_HEME_FROM_PLASMA | 2.18e-05 | 69 | 34 | 4 | M27150 | |
| Pathway | REACTOME_DIGESTION | 2.20e-05 | 23 | 34 | 3 | M27790 | |
| Pathway | REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION | 2.44e-05 | 71 | 34 | 4 | M27203 | |
| Pathway | REACTOME_DIGESTION_AND_ABSORPTION | 4.03e-05 | 28 | 34 | 3 | M27837 | |
| Pathway | REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS | 4.32e-05 | 82 | 34 | 4 | M27110 | |
| Pathway | REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR | 4.50e-05 | 166 | 34 | 5 | M608 | |
| Pathway | REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION | 5.21e-05 | 86 | 34 | 4 | M27206 | |
| Pathway | REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION | 5.45e-05 | 87 | 34 | 4 | M27205 | |
| Pathway | REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS | 7.69e-05 | 95 | 34 | 4 | M29842 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_COMPLEMENT_CASCADE_CFHR | 8.42e-05 | 6 | 34 | 2 | M47880 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 8.55e-05 | 190 | 34 | 5 | M8240 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 9.43e-05 | 194 | 34 | 5 | M16312 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 1.18e-04 | 7 | 34 | 2 | M46421 | |
| Pathway | REACTOME_LEISHMANIA_INFECTION | 1.67e-04 | 219 | 34 | 5 | M29836 | |
| Pathway | REACTOME_PARASITE_INFECTION | 1.67e-04 | 116 | 34 | 4 | M29843 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION | 2.01e-04 | 9 | 34 | 2 | M27810 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_MRNA_TRANSLATION | 2.01e-04 | 9 | 34 | 2 | M46436 | |
| Pathway | REACTOME_REGULATION_OF_CDH11_MRNA_TRANSLATION_BY_MICRORNAS | 2.51e-04 | 10 | 34 | 2 | M48013 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 2.61e-04 | 52 | 34 | 3 | M14171 | |
| Pathway | REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION | 3.07e-04 | 136 | 34 | 4 | M27207 | |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | 3.72e-04 | 143 | 34 | 4 | M27107 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_GENE_EXPRESSION | 4.33e-04 | 13 | 34 | 2 | M46434 | |
| Pathway | REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS | 4.92e-04 | 154 | 34 | 4 | M39007 | |
| Pathway | REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY | 7.51e-04 | 17 | 34 | 2 | M27788 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_APOPTOSIS | 9.41e-04 | 19 | 34 | 2 | M48238 | |
| Pathway | REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING | 9.99e-04 | 186 | 34 | 4 | M27175 | |
| Pathway | WP_COMPLEMENT_SYSTEM | 1.57e-03 | 96 | 34 | 3 | M39581 | |
| Pathway | REACTOME_TGFBR3_EXPRESSION | 2.05e-03 | 28 | 34 | 2 | M48253 | |
| Pathway | REACTOME_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION | 2.68e-03 | 32 | 34 | 2 | M48012 | |
| Pathway | REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY | 2.68e-03 | 32 | 34 | 2 | M27900 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_NPAS4 | 3.02e-03 | 34 | 34 | 2 | M46422 | |
| Pathway | REACTOME_ONCOGENE_INDUCED_SENESCENCE | 3.20e-03 | 35 | 34 | 2 | M27190 | |
| Pathway | REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX | 3.57e-03 | 37 | 34 | 2 | M29790 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 3.96e-03 | 39 | 34 | 2 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 3.96e-03 | 39 | 34 | 2 | MM15165 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_VENTX | 4.37e-03 | 41 | 34 | 2 | M29748 | |
| Pathway | REACTOME_INNATE_IMMUNE_SYSTEM | 4.55e-03 | 1128 | 34 | 8 | M1036 | |
| Pathway | REACTOME_SARS_COV_INFECTIONS | 5.09e-03 | 471 | 34 | 5 | M39009 | |
| Pathway | REACTOME_HEMOSTASIS | 5.18e-03 | 679 | 34 | 6 | M8395 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 5.70e-03 | 47 | 34 | 2 | M29777 | |
| Pathway | REACTOME_SIGNALING_BY_TGFBR3 | 6.19e-03 | 49 | 34 | 2 | M48250 | |
| Pubmed | 2.47e-09 | 3 | 48 | 3 | 15299664 | ||
| Pubmed | 2.47e-09 | 3 | 48 | 3 | 32697825 | ||
| Pubmed | 2.47e-09 | 3 | 48 | 3 | 12527308 | ||
| Pubmed | 2.47e-09 | 3 | 48 | 3 | 6176528 | ||
| Pubmed | State and trait variance in salivary α-amylase: a behavioral genetic study. | 2.47e-09 | 3 | 48 | 3 | 21827821 | |
| Pubmed | 2.47e-09 | 3 | 48 | 3 | 30982860 | ||
| Pubmed | 2.47e-09 | 3 | 48 | 3 | 22063648 | ||
| Pubmed | 2.47e-09 | 3 | 48 | 3 | 25588701 | ||
| Pubmed | Sequence and evolution of the human germline V lambda repertoire. | 7.36e-09 | 49 | 48 | 5 | 8951372 | |
| Pubmed | 9.86e-09 | 4 | 48 | 3 | 2423416 | ||
| Pubmed | Regional assignment of human amylase (AMY) to p22----p21 of chromosome 1. | 4.92e-08 | 6 | 48 | 3 | 6608795 | |
| Pubmed | 4.92e-08 | 6 | 48 | 3 | 2081604 | ||
| Pubmed | 4.92e-08 | 6 | 48 | 3 | 15286789 | ||
| Pubmed | 4.92e-08 | 6 | 48 | 3 | 2452973 | ||
| Pubmed | The human alpha-amylase multigene family consists of haplotypes with variable numbers of genes. | 4.92e-08 | 6 | 48 | 3 | 2788608 | |
| Pubmed | 1.37e-07 | 8 | 48 | 3 | 12414807 | ||
| Pubmed | Two-hybrid analysis of human salivary mucin MUC7 interactions. | 2.06e-07 | 9 | 48 | 3 | 16203048 | |
| Pubmed | Salivary protein profiles are linked to bitter taste acceptance in infants. | 4.04e-07 | 11 | 48 | 3 | 24248522 | |
| Pubmed | One-megabase sequence analysis of the human immunoglobulin lambda gene locus. | 4.24e-07 | 109 | 48 | 5 | 9074928 | |
| Pubmed | 8.88e-07 | 14 | 48 | 3 | 7894156 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 28219410 | ||
| Pubmed | TDP-43 enhances translation of specific mRNAs linked to neurodegenerative disease. | 5.59e-06 | 3 | 48 | 2 | 30357366 | |
| Pubmed | Impact of scaffolding protein TNRC6 paralogs on gene expression and splicing. | 5.59e-06 | 3 | 48 | 2 | 34108231 | |
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 10622723 | ||
| Pubmed | Two factor H-related proteins from the mouse: expression analysis and functional characterization. | 5.59e-06 | 3 | 48 | 2 | 17028856 | |
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 25684976 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 16880270 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 21637784 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 31670606 | ||
| Pubmed | 7.05e-06 | 27 | 48 | 3 | 26544073 | ||
| Pubmed | The human and mouse repertoire of the adhesion family of G-protein-coupled receptors. | 8.79e-06 | 29 | 48 | 3 | 15203201 | |
| Pubmed | Low Copy Number of the AMY1 Locus Is Associated with Early-Onset Female Obesity in Finland. | 1.12e-05 | 4 | 48 | 2 | 26132294 | |
| Pubmed | Characterization of the amino termini of mouse salivary and pancreatic amylases. | 1.12e-05 | 4 | 48 | 2 | 6165618 | |
| Pubmed | Multiple polyadenylation sites in a mouse alpha-amylase gene. | 1.12e-05 | 4 | 48 | 2 | 6166922 | |
| Pubmed | A single mouse alpha-amylase gene specifies two different tissue-specific mRNAs. | 1.12e-05 | 4 | 48 | 2 | 6162570 | |
| Pubmed | Additional evidence for the close linkage of amy-1 and amy-2 in the mouse. | 1.12e-05 | 4 | 48 | 2 | 6163812 | |
| Pubmed | Structural forms of the human amylase locus and their relationships to SNPs, haplotypes and obesity. | 1.12e-05 | 4 | 48 | 2 | 26098870 | |
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 6160849 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 36793547 | ||
| Pubmed | Members of the Amy-2 alpha-amylase gene family of mouse strain CE/J contain duplicated 5' termini. | 1.12e-05 | 4 | 48 | 2 | 2987507 | |
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 24279761 | ||
| Pubmed | Electrophoretic variation of alpha-amylase in two inbred strains of Mus musculus. | 1.12e-05 | 4 | 48 | 2 | 4745489 | |
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 6091898 | ||
| Pubmed | Gentic polymorphism of amylase isoenzymes in feral populations of the house mouse. | 1.12e-05 | 4 | 48 | 2 | 1141004 | |
| Pubmed | Genetic variation in mouse salivary amylase rate of synthesis. | 1.12e-05 | 4 | 48 | 2 | 94264 | |
| Pubmed | Genetic regulation of GM4(NeuAc) expression in mouse erythrocytes. | 1.12e-05 | 4 | 48 | 2 | 2332419 | |
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 3872721 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 6157477 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 6176715 | ||
| Pubmed | Mouse liver and salivary gland alpha-amylase mRNAs differ only in 5' non-translated sequences. | 1.12e-05 | 4 | 48 | 2 | 6162108 | |
| Pubmed | Two PABPC1-binding sites in GW182 proteins promote miRNA-mediated gene silencing. | 1.12e-05 | 4 | 48 | 2 | 21063388 | |
| Pubmed | Simultaneous expression of salivary and pancreatic amylase genes in cultured mouse hepatoma cells. | 1.12e-05 | 4 | 48 | 2 | 2431276 | |
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 16152770 | ||
| Pubmed | Independent regulation of nonallelic pancreatic amylase genes in diabetic mice. | 1.12e-05 | 4 | 48 | 2 | 6207174 | |
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 2410924 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 2476716 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 6161122 | ||
| Pubmed | Expression of mouse Amy-2a alpha-amylase genes is regulated by strong pancreas-specific promoters. | 1.12e-05 | 4 | 48 | 2 | 3877171 | |
| Pubmed | Mouse alpha-amylase loci, Amy-1a and Amy-2a, are closely linked. | 1.12e-05 | 4 | 48 | 2 | 2989529 | |
| Pubmed | International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors. | 1.31e-05 | 33 | 48 | 3 | 25713288 | |
| Pubmed | 1.71e-05 | 36 | 48 | 3 | 7558020 | ||
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 20042240 | ||
| Pubmed | Factor H-related proteins determine complement-activating surfaces. | 1.86e-05 | 5 | 48 | 2 | 25979655 | |
| Pubmed | Genetic mapping of the IL-12 alpha chain gene (Il12a) on mouse chromosome 3. | 1.86e-05 | 5 | 48 | 2 | 8661735 | |
| Pubmed | Ago-TNRC6 triggers microRNA-mediated decay by promoting two deadenylation steps. | 1.86e-05 | 5 | 48 | 2 | 19838187 | |
| Pubmed | Identification and sequence analysis of four complement factor H-related transcripts in mouse liver. | 1.86e-05 | 5 | 48 | 2 | 1689298 | |
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 6529441 | ||
| Pubmed | A radiation hybrid map of complement factor H and factor H-related genes. | 1.86e-05 | 5 | 48 | 2 | 10380701 | |
| Pubmed | Murine Salivary Amylase Protects Against Streptococcus mutans-Induced Caries. | 1.86e-05 | 5 | 48 | 2 | 34276419 | |
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 6176569 | ||
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 1348427 | ||
| Pubmed | 2.79e-05 | 6 | 48 | 2 | 7946325 | ||
| Pubmed | Ampd-2 maps to distal mouse chromosome 3 in linkage with Ampd-1. | 2.79e-05 | 6 | 48 | 2 | 2328996 | |
| Pubmed | Genetics of hydroxyacid oxidase isozymes in the mouse: localisation of Hao-2 on linkage group XVI. | 2.79e-05 | 6 | 48 | 2 | 284003 | |
| Pubmed | A fibrillar collagen gene, Col11a1, is essential for skeletal morphogenesis. | 2.79e-05 | 6 | 48 | 2 | 7859283 | |
| Pubmed | 2.79e-05 | 6 | 48 | 2 | 27196323 | ||
| Pubmed | 2.79e-05 | 6 | 48 | 2 | 2002257 | ||
| Pubmed | 2.79e-05 | 6 | 48 | 2 | 17438673 | ||
| Pubmed | 2.79e-05 | 6 | 48 | 2 | 28806758 | ||
| Pubmed | 2.79e-05 | 6 | 48 | 2 | 2450406 | ||
| Pubmed | The mouse urate oxidase gene, Uox, maps to distal chromosome 3. | 2.79e-05 | 6 | 48 | 2 | 9250879 | |
| Pubmed | Linkage of the cadmium resistance locus to loci on mouse chromosome 12. | 2.79e-05 | 6 | 48 | 2 | 1021597 | |
| Pubmed | 2.93e-05 | 43 | 48 | 3 | 1249422 | ||
| Pubmed | 3.83e-05 | 47 | 48 | 3 | 814163 | ||
| Pubmed | 3.90e-05 | 7 | 48 | 2 | 6160178 | ||
| Pubmed | Rostral cerebellar malformation, (rcm): a new recessive mutation on chromosome 3 of the mouse. | 3.90e-05 | 7 | 48 | 2 | 1401878 | |
| Pubmed | 3.90e-05 | 7 | 48 | 2 | 8604219 | ||
| Pubmed | Analysis of the mouse Amy locus in recombinant inbred mouse strains. | 3.90e-05 | 7 | 48 | 2 | 2451911 | |
| Pubmed | 3.90e-05 | 7 | 48 | 2 | 8666240 | ||
| Pubmed | 3.90e-05 | 7 | 48 | 2 | 19383768 | ||
| Pubmed | 3.90e-05 | 7 | 48 | 2 | 7949740 | ||
| Pubmed | Functional dissection of the human TNRC6 (GW182-related) family of proteins. | 3.90e-05 | 7 | 48 | 2 | 19470757 | |
| Pubmed | 3.90e-05 | 7 | 48 | 2 | 19861685 | ||
| Pubmed | 4.08e-05 | 48 | 48 | 3 | 11955599 | ||
| Pubmed | 5.19e-05 | 8 | 48 | 2 | 2824476 | ||
| Pubmed | Linkage relationships among eleven biochemical loci in Peromyscus. | 5.19e-05 | 8 | 48 | 2 | 6200103 | |
| Pubmed | 5.19e-05 | 8 | 48 | 2 | 8486361 | ||
| Pubmed | Murine VCAM-1. Molecular cloning, mapping, and analysis of a truncated form. | 5.19e-05 | 8 | 48 | 2 | 7523515 | |
| Pubmed | 5.19e-05 | 8 | 48 | 2 | 2040456 | ||
| Pubmed | 5.19e-05 | 8 | 48 | 2 | 3038891 | ||
| Interaction | HELZ interactions | 2.48e-05 | 257 | 46 | 6 | int:HELZ | |
| Interaction | ODF2 interactions | 2.94e-05 | 158 | 46 | 5 | int:ODF2 | |
| Interaction | KIZ interactions | 3.13e-05 | 27 | 46 | 3 | int:KIZ | |
| Interaction | CNTROB interactions | 3.72e-05 | 166 | 46 | 5 | int:CNTROB | |
| Interaction | ARL16 interactions | 3.83e-05 | 83 | 46 | 4 | int:ARL16 | |
| Interaction | GARRE1 interactions | 3.83e-05 | 167 | 46 | 5 | int:GARRE1 | |
| Interaction | HTN3 interactions | 4.33e-05 | 30 | 46 | 3 | int:HTN3 | |
| Interaction | ZFP36 interactions | 5.62e-05 | 181 | 46 | 5 | int:ZFP36 | |
| Interaction | CNOT6L interactions | 5.98e-05 | 93 | 46 | 4 | int:CNOT6L | |
| Interaction | CEP192 interactions | 7.44e-05 | 192 | 46 | 5 | int:CEP192 | |
| Interaction | ETV6 interactions | 9.59e-05 | 105 | 46 | 4 | int:ETV6 | |
| Interaction | CEP120 interactions | 9.95e-05 | 106 | 46 | 4 | int:CEP120 | |
| Interaction | CNOT11 interactions | 1.23e-04 | 112 | 46 | 4 | int:CNOT11 | |
| Interaction | SAMD4B interactions | 1.71e-04 | 122 | 46 | 4 | int:SAMD4B | |
| Interaction | CNOT9 interactions | 1.77e-04 | 231 | 46 | 5 | int:CNOT9 | |
| Interaction | R3HDM2 interactions | 2.12e-04 | 129 | 46 | 4 | int:R3HDM2 | |
| Interaction | BICD1 interactions | 2.55e-04 | 250 | 46 | 5 | int:BICD1 | |
| Interaction | TNRC6C interactions | 2.75e-04 | 138 | 46 | 4 | int:TNRC6C | |
| Interaction | CNOT6 interactions | 2.83e-04 | 56 | 46 | 3 | int:CNOT6 | |
| Interaction | XRN1 interactions | 2.95e-04 | 258 | 46 | 5 | int:XRN1 | |
| Interaction | CPEB1 interactions | 3.41e-04 | 146 | 46 | 4 | int:CPEB1 | |
| Interaction | CEP135 interactions | 3.76e-04 | 272 | 46 | 5 | int:CEP135 | |
| Interaction | CPEB4 interactions | 4.38e-04 | 156 | 46 | 4 | int:CPEB4 | |
| Interaction | PAN3 interactions | 4.40e-04 | 65 | 46 | 3 | int:PAN3 | |
| Interaction | TNRC6B interactions | 4.44e-04 | 282 | 46 | 5 | int:TNRC6B | |
| Interaction | IQCC interactions | 4.56e-04 | 14 | 46 | 2 | int:IQCC | |
| Interaction | SSX2IP interactions | 4.89e-04 | 288 | 46 | 5 | int:SSX2IP | |
| Interaction | DCP1A interactions | 5.53e-04 | 166 | 46 | 4 | int:DCP1A | |
| Interaction | CEP295 interactions | 5.71e-04 | 71 | 46 | 3 | int:CEP295 | |
| Interaction | CEP85 interactions | 5.92e-04 | 169 | 46 | 4 | int:CEP85 | |
| Interaction | FAM184A interactions | 5.94e-04 | 72 | 46 | 3 | int:FAM184A | |
| Interaction | CNOT8 interactions | 6.44e-04 | 74 | 46 | 3 | int:CNOT8 | |
| Interaction | PATL1 interactions | 7.04e-04 | 177 | 46 | 4 | int:PATL1 | |
| Interaction | CNOT2 interactions | 7.19e-04 | 178 | 46 | 4 | int:CNOT2 | |
| Interaction | DEUP1 interactions | 7.23e-04 | 77 | 46 | 3 | int:DEUP1 | |
| Interaction | CTIF interactions | 7.23e-04 | 77 | 46 | 3 | int:CTIF | |
| Interaction | CEP63 interactions | 7.34e-04 | 179 | 46 | 4 | int:CEP63 | |
| Interaction | CEP152 interactions | 7.34e-04 | 179 | 46 | 4 | int:CEP152 | |
| Interaction | CPAP interactions | 7.81e-04 | 182 | 46 | 4 | int:CPAP | |
| Interaction | ENTR1 interactions | 8.81e-04 | 188 | 46 | 4 | int:ENTR1 | |
| Interaction | FAM120C interactions | 9.35e-04 | 191 | 46 | 4 | int:FAM120C | |
| Cytoband | 22q11.2 | 1.76e-07 | 120 | 48 | 5 | 22q11.2 | |
| Cytoband | 1p21 | 2.14e-06 | 24 | 48 | 3 | 1p21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr22q11 | 4.95e-06 | 419 | 48 | 6 | chr22q11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p21 | 1.97e-04 | 107 | 48 | 3 | chr1p21 | |
| Cytoband | 1q32 | 1.22e-03 | 49 | 48 | 2 | 1q32 | |
| Cytoband | 1p13.3 | 2.40e-03 | 69 | 48 | 2 | 1p13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q31 | 2.83e-03 | 75 | 48 | 2 | chr1q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3q27 | 8.00e-03 | 128 | 48 | 2 | chr3q27 | |
| GeneFamily | Immunoglobulin lambda locus at 22q11.2 | 6.41e-07 | 89 | 34 | 5 | 353 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 3.84e-06 | 57 | 34 | 4 | 1179 | |
| GeneFamily | Neuroblastoma breakpoint family | 8.47e-04 | 23 | 34 | 2 | 662 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 1.00e-03 | 25 | 34 | 2 | 775 | |
| GeneFamily | Complement system|Sushi domain containing | 2.08e-03 | 36 | 34 | 2 | 492 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.42e-08 | 179 | 47 | 6 | 494febe77c6d4e6a2c6f0928bbf4c84b0301f188 | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 4.43e-08 | 187 | 47 | 6 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-GRIA2+_arterial_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.58e-08 | 188 | 47 | 6 | 366a2d59b9c81d8a7659749f9c07efa46b49a39a | |
| ToppCell | COVID_vent-Lymphocytic-Plasma_cell-IgM_Plasmablast|COVID_vent / Disease condition, Lineage, Cell class and subclass | 5.86e-08 | 196 | 47 | 6 | 026a06d8d2089806823e6f6453d3ede84ae93bc6 | |
| ToppCell | COVID_non-vent-Lymphocytic-Plasma_cell-IgA_Plasmablast|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 6.04e-08 | 197 | 47 | 6 | fdbf4eb9fa5aefb4ffb307494fe4774bf5e0aaeb | |
| ToppCell | 3'_v3-Lung-Lymphocytic_B_plasma-Plasma_cells|Lung / Manually curated celltypes from each tissue | 8.20e-07 | 164 | 47 | 5 | 3b6a32ba53d05f6818fe950ac426f489383b645a | |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell-IgM_Plasmablast|healthy_donor / Disease condition, Lineage, Cell class and subclass | 8.71e-07 | 166 | 47 | 5 | 2b7b580bec8d9467b0deaf97098065f72dbf2a4f | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-Plasma_cells-IgG_plasma_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.51e-07 | 169 | 47 | 5 | 0c2384f780ec25710ebb35c0b0df8f4afb53c9b1 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.07e-06 | 173 | 47 | 5 | 0ca2169a275404118038c0489a48062879488765 | |
| ToppCell | facs-Aorta|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-06 | 176 | 47 | 5 | 0b3491451be02c18a16cdb875645be47eb867a7f | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.19e-06 | 177 | 47 | 5 | 4c434a7b7cc54cf4dac996bbc3f5124d9ef9a9cd | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.19e-06 | 177 | 47 | 5 | fc40918825b7e1eb6861df59dfca944778a64b98 | |
| ToppCell | tumor_Lung-B_lymphocytes-MALT_B_cells|tumor_Lung / Location, Cell class and cell subclass | 1.19e-06 | 177 | 47 | 5 | 37e03f51925345f5f716ef3abe1d2c4ccf129020 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.19e-06 | 177 | 47 | 5 | d746122bf8d208c3aa4d156e8c12d0a0e555c6e5 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.23e-06 | 178 | 47 | 5 | 107dae8b00c4257697a63700e72bb434cdb8406f | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.26e-06 | 179 | 47 | 5 | 837ed81f18257f444eaeadc4fac89deedd4e3061 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.26e-06 | 179 | 47 | 5 | b6ee4f41d8fb5f047b7bdd8489dda0a89fc6d43f | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.30e-06 | 180 | 47 | 5 | cea079bc02e08c46600eed05ab9924ec90e1e3d3 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.30e-06 | 180 | 47 | 5 | e3877f6ef5f54ff689058b4c996ab1851822f871 | |
| ToppCell | cellseq-Immune-Lymphocytic_B|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.30e-06 | 180 | 47 | 5 | 663a800ab70e7ab7d13183417f9c1ed36907aa5e | |
| ToppCell | cellseq-Immune-Lymphocytic_B-Lymphocytic_B|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.30e-06 | 180 | 47 | 5 | cd04d7bf92986a5b8a0193c9b92ec47da3929bac | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_mature-endo_arterial_(9)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.30e-06 | 180 | 47 | 5 | 5861b44acfb8fe92c281c8355bf19c059b3dcd64 | |
| ToppCell | BAL-Mild-Lymphocyte-B|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.33e-06 | 181 | 47 | 5 | 700adfb41e4e377530f0dd31be89e12f109f3469 | |
| ToppCell | Mild-Lymphoid-B|Mild / Condition, Lineage, Cell class and cell subclass | 1.41e-06 | 183 | 47 | 5 | 9b64d2d143525e6f48a191facfd101462ff36324 | |
| ToppCell | Mild_COVID-19-B_cell|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.41e-06 | 183 | 47 | 5 | dea119e2988e954475f557f0bbe12556a83e81a4 | |
| ToppCell | Mild-Lymphoid-B-|Mild / Condition, Lineage, Cell class and cell subclass | 1.41e-06 | 183 | 47 | 5 | b5740f05a4dcdbbf24f7bf7a3f57ac01a5e75f60 | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.45e-06 | 184 | 47 | 5 | 3f8a359e40bebe58545f708682e5e5d1b70cf5cb | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.45e-06 | 184 | 47 | 5 | 64bede8db709fd32f40c03265b96f0b12155bb8a | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.48e-06 | 185 | 47 | 5 | 609080adb2cfb105bb7b8efb617553833299f371 | |
| ToppCell | Mild_COVID-19-B_cell-B_cell|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.52e-06 | 186 | 47 | 5 | 855a5a00ba2aa1b5c63b8db56d026ddecc546050 | |
| ToppCell | wk_08-11-Endothelial-Blood_vessel_endothelial-GRIA2+_arterial_endo|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.57e-06 | 187 | 47 | 5 | a27aa97aa6508a3ffe92c2b6bb0511a95650a390 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-B_lymphocytic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.61e-06 | 188 | 47 | 5 | c3cae529fdbeb233d2b32bcc3537a8aba26a7dc2 | |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.61e-06 | 188 | 47 | 5 | bd53b0371154cff680226897b61c9809a239d1b6 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.69e-06 | 190 | 47 | 5 | 79ee6d10dfbb775da149a1104da5823cf63bbb46 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_mature-endo_arterial_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.69e-06 | 190 | 47 | 5 | 1307688255a1250fa300edf2c41f1affe31dcc98 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.69e-06 | 190 | 47 | 5 | 18762ce78ed0b206ade19e1c8ff76a2647489f68 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-Plasma_cells|B_lymphocytes / Location, Cell class and cell subclass | 1.78e-06 | 192 | 47 | 5 | 119832d4aee29ddda2485fc3e5dcdaacf833cc30 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-B_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.83e-06 | 193 | 47 | 5 | e9bbc2c4516341524686aa095aae4ae7e80a688a | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-06 | 193 | 47 | 5 | 1f978e102a029a6beb10913052cd0a20c7253e8e | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgG_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.87e-06 | 194 | 47 | 5 | f083777353e76a2d9c39f8b6cb1a689b68b81c56 | |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | 1.87e-06 | 194 | 47 | 5 | b6cc849fa08599bff9839ef382d190cc964e273e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.87e-06 | 194 | 47 | 5 | fa6d51f36a3dae8763a595c20892987ed454c0f0 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.87e-06 | 194 | 47 | 5 | 23f2a627226aaed468c55adc42ab22e051dfe7fe | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B-B_lineage-immature_B_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.92e-06 | 195 | 47 | 5 | ecaaa3d071e763c40d05d088fbf9e8ca06f78f47 | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-GRIA2+_arterial_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.92e-06 | 195 | 47 | 5 | a432d69b0172211ee4d53675936a1dc9ce1ae1f0 | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-B|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.02e-06 | 197 | 47 | 5 | 88b29d205237f07a9a26cc15a1cf4ed4816a4c4b | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.02e-06 | 197 | 47 | 5 | 76465bb2408c7c75f694e8f7cf1a606b796afc3a | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.02e-06 | 197 | 47 | 5 | 9fe1b757f76c2d43d39aa9ac500eaba98723985c | |
| ToppCell | COVID_non-vent-Lymphocytic-Plasma_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.02e-06 | 197 | 47 | 5 | 1e63879633f20646e44873ae6b662f6faf4806fd | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.12e-06 | 199 | 47 | 5 | 0d63da0afa93741c37609d879941de202d9ac86c | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Artery|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 2.18e-06 | 200 | 47 | 5 | 34b279804475ea58fbb052b96f44128c082627a9 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Artery|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.18e-06 | 200 | 47 | 5 | 8552cc7a439449b30b59760c3e8667217b9852b5 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Artery-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.18e-06 | 200 | 47 | 5 | 45c08f1befe78553bbadcc2fcffb6138306638f3 | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-Plasma_cells|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.53e-05 | 142 | 47 | 4 | 5ba3a33c2ee20be8baaed97536ca6e9d1de6752f | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.70e-05 | 146 | 47 | 4 | 2d907e50206c4762a8baa741363bc7f0a04bd84e | |
| ToppCell | TCGA-Lung|World / Sample_Type by Project: Shred V9 | 1.89e-05 | 150 | 47 | 4 | 8c133206786e8f22bb70f2a7de9c0cb7f9ea9313 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c6-FGF23|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.99e-05 | 152 | 47 | 4 | 0652ee3443e6fbb679d2c4f326239ae7c803f924 | |
| ToppCell | normal_Lung-B_lymphocytes-MALT_B_cells|normal_Lung / Location, Cell class and cell subclass | 2.38e-05 | 159 | 47 | 4 | fbd0131b66f4267f7b0d6c3ad874ad097b859074 | |
| ToppCell | COVID-naiveBc-|COVID / Condition, Cell_class and T cell subcluster | 2.38e-05 | 159 | 47 | 4 | 4e6783b0f69c0c70150f9f3594881dc1bac7038a | |
| ToppCell | COVID-naiveBc|COVID / Condition, Cell_class and T cell subcluster | 2.38e-05 | 159 | 47 | 4 | 52cd36b4412f69a935b3f76da96c166a9481eb0c | |
| ToppCell | 3'_v3-Lung-Lymphocytic_B_plasma|Lung / Manually curated celltypes from each tissue | 3.02e-05 | 169 | 47 | 4 | a65853ff9f6489cc1617cbba0d03b392d23c1528 | |
| ToppCell | BAL-Mild-Lymphocyte-B|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.02e-05 | 169 | 47 | 4 | 307571e57c3bfdf15f0fe1a8b36585e8e4f8a207 | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell-B_activate-7|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.09e-05 | 170 | 47 | 4 | ee2ee67d90ae4596de8ccd620e37c82cf51651d4 | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.09e-05 | 170 | 47 | 4 | d7ca0c6ce5d2b7de99346f87e07aa7fe728fa08a | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.09e-05 | 170 | 47 | 4 | 52787f6d529c285d9f0c04cc022710ead5b89b3f | |
| ToppCell | metastatic_Brain-B_lymphocytes-Plasma_cells|metastatic_Brain / Location, Cell class and cell subclass | 3.09e-05 | 170 | 47 | 4 | 53634da9e9c72f6400639954c286c6e38ea5a188 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.09e-05 | 170 | 47 | 4 | 1a568efcff9c39b3f709b55a05d24710450a2657 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.09e-05 | 170 | 47 | 4 | 66d41d794790e621d72ac37af995510537103c9c | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.24e-05 | 172 | 47 | 4 | 172e3c78f8e97988a4fd8624514e731282ddc16d | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.24e-05 | 172 | 47 | 4 | 5fb0ea6145892a258696197b3feed9760187e712 | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.24e-05 | 172 | 47 | 4 | 2214cc37d7c21b868768d3f74ca4631d339d37b3 | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.24e-05 | 172 | 47 | 4 | 07620728a6cdeea805e1365e588be096c17a370c | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Endothelial-endothelial_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-05 | 173 | 47 | 4 | 2a5ea28c65dd4ee03ba3d0bfe0c819b1d583f8da | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Endothelial|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-05 | 173 | 47 | 4 | 6a7e4fa2d9d00f50decc89b535d8a68ec96de58a | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.31e-05 | 173 | 47 | 4 | 7e6bfe85f60834f317941b70d6e0dc3bd527d293 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B_plasma|bone_marrow / Manually curated celltypes from each tissue | 3.39e-05 | 174 | 47 | 4 | b1931028cf80af5eff6da15d7f0196205f17926f | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.54e-05 | 176 | 47 | 4 | 77516048aefbe1f48e825052756df0c310c1c486 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.54e-05 | 176 | 47 | 4 | 96779273b94345250cf53ba671203345b43d9e00 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.62e-05 | 177 | 47 | 4 | c2b0fb5921eea24d248d6e6ccb57c29b0832602c | |
| ToppCell | -IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 3.62e-05 | 177 | 47 | 4 | ae2d2e138946535596fa30a55207f261cafda461 | |
| ToppCell | (2)_Plasma_cells|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.62e-05 | 177 | 47 | 4 | ed3c936bb69f9bc7291b4f6cde1d204078117c48 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.62e-05 | 177 | 47 | 4 | 111fb0707ff37ca631d85bb5a09e067ffe568eb8 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage-naive_B_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.62e-05 | 177 | 47 | 4 | 325c10674b18727ddd50bf088a9c6f4ef29aa809 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-B_cells-Immature_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.70e-05 | 178 | 47 | 4 | 2e51c1596022b7047994ee13c18375bad19a54a5 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-Plasma_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.70e-05 | 178 | 47 | 4 | 693f1135d9c5545945e80c7ba3d098afc0ccac29 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-B_cells-Pre-B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.70e-05 | 178 | 47 | 4 | 34ef4d36ddfb1cdeaaaf5d952e1ad6dc2785ce1e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.70e-05 | 178 | 47 | 4 | 6765c6970b1f2b719a20d2afd7471e1c262f3fc4 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-endo_arterial_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.70e-05 | 178 | 47 | 4 | c227da59dc7beb73f84405bf13356bdeb59d9338 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-Plasma_cells-IgG_plasma_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.86e-05 | 180 | 47 | 4 | 588461d603dafa74e274a1dea021fd568e7f7875 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-B_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.95e-05 | 181 | 47 | 4 | e7d9910f6143055645b6f03b1018282e6c215f10 | |
| ToppCell | 356C-Lymphocytic-Plasma_cell|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.95e-05 | 181 | 47 | 4 | f1d88b83a13acd1c8e6b9ff8bd0acaff3650ceef | |
| ToppCell | 356C-Lymphocytic-Plasma_cell-|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.95e-05 | 181 | 47 | 4 | 70cd612706640d8ebf0e047582b1daa2c1121526 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-Plasma_cells|normal_Lymph_Node / Location, Cell class and cell subclass | 3.95e-05 | 181 | 47 | 4 | 949ac3b60e7fb5968da4c4e872965fb4e10f4a35 | |
| ToppCell | PND07-28-samps-Endothelial-Postnatal_endothelial-capillary_endothelial_Hpgd-CA4_high|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.95e-05 | 181 | 47 | 4 | 9cd5e5c285c2b628db9d59709af053defd7c0aff | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.95e-05 | 181 | 47 | 4 | 2c660fcf0404c155955b67ab2958d6e6b0e30024 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.03e-05 | 182 | 47 | 4 | 1bf2e4fd6222b41a7d08df6dcc500c9401db8c18 | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l19|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.03e-05 | 182 | 47 | 4 | 840427d1c23d60482c943ff006b14007ed44d247 | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-Plasma_cells|B_lymphocytes / Location, Cell class and cell subclass | 4.03e-05 | 182 | 47 | 4 | 27d1688fdfc570cedd233aa7030bce7d9b604d42 | |
| ToppCell | COVID-19-kidney-CD-IC-A|kidney / Disease (COVID-19 only), tissue and cell type | 4.12e-05 | 183 | 47 | 4 | 5c7597a5b2bf6a481ca2c7e68560179214150fa0 | |
| ToppCell | cellseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.12e-05 | 183 | 47 | 4 | 5ab4aa0304b832f98fff89b6c24ad5b7dd014c11 | |
| Drug | trestatin A | 1.52e-09 | 9 | 44 | 4 | CID003054994 | |
| Drug | AC1N3UXZ | 6.73e-09 | 3 | 44 | 3 | CID004118625 | |
| Drug | Dembrexine | 2.69e-08 | 4 | 44 | 3 | CID000072009 | |
| Drug | g lw | 2.69e-08 | 4 | 44 | 3 | CID000444139 | |
| Drug | AC1MQT4V | 2.69e-08 | 4 | 44 | 3 | CID003482066 | |
| Drug | beta-santalene | 2.69e-08 | 4 | 44 | 3 | CID000010534 | |
| Drug | 2-nitropropyl acetate | 2.69e-08 | 4 | 44 | 3 | CID013573844 | |
| Drug | N-PMT | 2.69e-08 | 4 | 44 | 3 | CID000194224 | |
| Drug | SAIB-SG | 2.69e-08 | 4 | 44 | 3 | CID002735139 | |
| Drug | cimicifugic acid A | 6.72e-08 | 5 | 44 | 3 | CID006449879 | |
| Drug | silver perchlorate | 6.72e-08 | 5 | 44 | 3 | CID000024562 | |
| Drug | actinidine | 6.72e-08 | 5 | 44 | 3 | CID000068231 | |
| Drug | Deposiston | 6.72e-08 | 5 | 44 | 3 | CID003080829 | |
| Drug | lunularic acid | 6.72e-08 | 5 | 44 | 3 | CID000161413 | |
| Drug | 2-[[(2-amino-1,3-thiazol-4-yl)-(2-oxoethylcarbamoyl)methylidene]amino]oxy-2-methyl-propanoic Acid | 6.72e-08 | 5 | 44 | 3 | CID010358258 | |
| Drug | himachalene | 6.72e-08 | 5 | 44 | 3 | CID000015095 | |
| Drug | 2TAA | 6.72e-08 | 5 | 44 | 3 | CID000127374 | |
| Drug | AC1L4DZ4 | 6.72e-08 | 5 | 44 | 3 | CID000155287 | |
| Drug | (2S)-2-acetamido-3-[(3E)-3-[(4-arsonophenyl)hydrazono]-4-oxo-cyclohexa-1,5-dien-1-yl]propanoic acid | 1.34e-07 | 6 | 44 | 3 | CID009577343 | |
| Drug | Borane dimethylamine complex | 1.34e-07 | 6 | 44 | 3 | CID009898794 | |
| Drug | AC1L3OV4 | 1.34e-07 | 6 | 44 | 3 | CID000092801 | |
| Drug | 4,6-O-3-ketobutylidene maltopentaose | 1.34e-07 | 6 | 44 | 3 | CID003083414 | |
| Drug | 2-amino-6-picoline | 1.34e-07 | 6 | 44 | 3 | CID000015765 | |
| Drug | CNP-G3 | 1.34e-07 | 6 | 44 | 3 | CID003082910 | |
| Drug | phenol blue | 1.34e-07 | 6 | 44 | 3 | CID000075078 | |
| Drug | AC1OAGH8 | 1.34e-07 | 6 | 44 | 3 | CID006857368 | |
| Drug | vermella | 1.34e-07 | 6 | 44 | 3 | CID000203726 | |
| Drug | R 623 | 1.34e-07 | 6 | 44 | 3 | CID003027594 | |
| Drug | Gu-4 | 1.34e-07 | 6 | 44 | 3 | CID000448679 | |
| Drug | hymenin | 1.34e-07 | 6 | 44 | 3 | CID000010499 | |
| Drug | tris(hydroxyethyl)aminomethane | 1.34e-07 | 6 | 44 | 3 | CID000448009 | |
| Drug | dimethylaminomethylferrocene | 1.34e-07 | 6 | 44 | 3 | CID000102082 | |
| Drug | mono-6-deoxy-6-fluorocyclomaltoheptaose | 1.34e-07 | 6 | 44 | 3 | CID000127364 | |
| Drug | mercuric thiocyanate | 1.34e-07 | 6 | 44 | 3 | CID000011615 | |
| Drug | CID439354 | 1.49e-07 | 25 | 44 | 4 | CID000439354 | |
| Drug | Paramax | 2.34e-07 | 7 | 44 | 3 | CID000156411 | |
| Drug | 3KBG5CNP | 2.34e-07 | 7 | 44 | 3 | CID003083250 | |
| Drug | AC1L9UU3 | 2.34e-07 | 7 | 44 | 3 | CID000071762 | |
| Drug | BG5P | 2.34e-07 | 7 | 44 | 3 | CID003082752 | |
| Drug | AC1L5BOU | 2.34e-07 | 7 | 44 | 3 | CID000174858 | |
| Drug | methyl blue | 2.34e-07 | 7 | 44 | 3 | CID011969534 | |
| Drug | amino-methyl | 2.34e-07 | 7 | 44 | 3 | CID000142005 | |
| Drug | boric acid gel | 3.75e-07 | 8 | 44 | 3 | CID003016474 | |
| Drug | AC1NSVJM | 3.75e-07 | 8 | 44 | 3 | CID005317411 | |
| Drug | theodrenaline | 3.75e-07 | 8 | 44 | 3 | CID000071857 | |
| Drug | rhodanile blue | 3.75e-07 | 8 | 44 | 3 | CID000073372 | |
| Drug | N-vinylcaprolactam | 3.75e-07 | 8 | 44 | 3 | CID000075227 | |
| Drug | 9-azidoacridine | 3.75e-07 | 8 | 44 | 3 | CID000146692 | |
| Drug | acrinor | 3.75e-07 | 8 | 44 | 3 | CID005489637 | |
| Drug | desethylaprophen | 3.75e-07 | 8 | 44 | 3 | CID000163919 | |
| Drug | azintamide | 3.75e-07 | 8 | 44 | 3 | CID000071105 | |
| Drug | NSC300622 | 3.75e-07 | 8 | 44 | 3 | CID000028426 | |
| Drug | Triap | 3.75e-07 | 8 | 44 | 3 | CID000013356 | |
| Drug | R625 | 4.76e-07 | 33 | 44 | 4 | CID000072375 | |
| Drug | Atonik | 5.61e-07 | 9 | 44 | 3 | CID000069471 | |
| Drug | GSAD | 5.61e-07 | 9 | 44 | 3 | CID009909127 | |
| Drug | zingiberene | 5.61e-07 | 9 | 44 | 3 | CID000092776 | |
| Drug | H 187 | 5.61e-07 | 9 | 44 | 3 | CID000001742 | |
| Drug | GU-3 | 5.61e-07 | 9 | 44 | 3 | CID000448687 | |
| Drug | alpha-maltosyl fluoride | 5.61e-07 | 9 | 44 | 3 | CID000194237 | |
| Drug | mercuric nitrate | 5.61e-07 | 9 | 44 | 3 | CID000024864 | |
| Drug | AC1LAC07 | 8.00e-07 | 10 | 44 | 3 | CID000485275 | |
| Drug | AC1L3M0Q | 8.00e-07 | 10 | 44 | 3 | CID000118008 | |
| Drug | I ZE | 8.00e-07 | 10 | 44 | 3 | CID009549200 | |
| Drug | Glc)4 | 8.00e-07 | 10 | 44 | 3 | CID000189098 | |
| Drug | eicosa-11,14-dienoic acid | 8.00e-07 | 10 | 44 | 3 | CID000003208 | |
| Drug | trans-cinnamamide | 8.00e-07 | 10 | 44 | 3 | CID000012135 | |
| Drug | CG-120 | 8.00e-07 | 10 | 44 | 3 | CID000171403 | |
| Drug | Ro 20-0083 | 8.00e-07 | 10 | 44 | 3 | CID003082332 | |
| Drug | UDP-pyridoxal | 8.00e-07 | 10 | 44 | 3 | CID000126789 | |
| Drug | naphthalene-1,3,6,8-tetrol | 8.00e-07 | 10 | 44 | 3 | CID000440202 | |
| Drug | S-p-nitrobenzyloxycarbonylglutathione | 9.50e-07 | 39 | 44 | 4 | CID004632704 | |
| Drug | validamycin D | 1.10e-06 | 11 | 44 | 3 | CID000166726 | |
| Drug | Tempamine | 1.10e-06 | 11 | 44 | 3 | CID000550942 | |
| Drug | HgI2 | 1.10e-06 | 11 | 44 | 3 | CID000024485 | |
| Drug | L-tert-leucine | 1.10e-06 | 11 | 44 | 3 | CID000164608 | |
| Drug | 2C KM | 1.10e-06 | 11 | 44 | 3 | CID009549196 | |
| Drug | AMO-1618 | 1.10e-06 | 11 | 44 | 3 | CID000017103 | |
| Drug | FG5P | 1.10e-06 | 11 | 44 | 3 | CID000127486 | |
| Drug | AC1L8PXO | 1.10e-06 | 11 | 44 | 3 | CID000430710 | |
| Drug | CNP-G5 | 1.10e-06 | 11 | 44 | 3 | CID000127309 | |
| Drug | AC1L4W0B | 1.46e-06 | 12 | 44 | 3 | CID000193311 | |
| Drug | chitosan | 1.46e-06 | 12 | 44 | 3 | CID000071853 | |
| Drug | azaprophen | 1.46e-06 | 12 | 44 | 3 | CID000129486 | |
| Drug | 3-hydr-oxy-2-naphthohydrazide | 1.46e-06 | 12 | 44 | 3 | CID000072699 | |
| Drug | H2folate | 1.46e-06 | 12 | 44 | 3 | CID000168809 | |
| Drug | chloroisocyanuric acid | 1.46e-06 | 12 | 44 | 3 | CID000017921 | |
| Drug | CTK2H7378 | 1.46e-06 | 12 | 44 | 3 | CID005462310 | |
| Drug | Avenin | 1.46e-06 | 12 | 44 | 3 | CID000095924 | |
| Drug | glyciphosphoramide | 1.46e-06 | 12 | 44 | 3 | CID000197092 | |
| Drug | GA15 | 1.90e-06 | 13 | 44 | 3 | CID000443453 | |
| Drug | dibromopropanol | 1.90e-06 | 13 | 44 | 3 | CID000007281 | |
| Drug | AC1L9AGE | 1.90e-06 | 13 | 44 | 3 | CID000441043 | |
| Drug | maltal | 1.90e-06 | 13 | 44 | 3 | CID000169427 | |
| Drug | pie-like | 1.90e-06 | 13 | 44 | 3 | CID000017384 | |
| Drug | AC1NTMU5 | 1.90e-06 | 13 | 44 | 3 | CID003035508 | |
| Drug | methyl 1'-epiacarviosin | 1.90e-06 | 13 | 44 | 3 | CID000197426 | |
| Drug | isoacarbose | 1.90e-06 | 13 | 44 | 3 | CID000449165 | |
| Drug | 8a-c | 1.90e-06 | 13 | 44 | 3 | CID000066085 | |
| Drug | AC1NBNXD | 1.90e-06 | 13 | 44 | 3 | CID004470981 | |
| Disease | NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial measurement | 1.24e-05 | 4 | 43 | 2 | EFO_0803292 | |
| Disease | solute carrier family 22 member 16 measurement | 3.10e-05 | 6 | 43 | 2 | EFO_0802079 | |
| Disease | Hemolytic-uremic syndrome | 7.42e-05 | 9 | 43 | 2 | cv:C0019061 | |
| Disease | Atypical hemolytic-uremic syndrome | 7.42e-05 | 9 | 43 | 2 | cv:C2931788 | |
| Disease | alpha-amylase 1 measurement | 7.42e-05 | 9 | 43 | 2 | EFO_0801371 | |
| Disease | diastolic blood pressure, systolic blood pressure | 4.00e-04 | 670 | 43 | 6 | EFO_0006335, EFO_0006336 | |
| Disease | aortic measurement | 4.86e-04 | 251 | 43 | 4 | EFO_0020865 | |
| Disease | amyotrophic lateral sclerosis (implicated_via_orthology) | 8.79e-04 | 30 | 43 | 2 | DOID:332 (implicated_via_orthology) | |
| Disease | Age related macular degeneration | 8.79e-04 | 30 | 43 | 2 | C0242383 | |
| Disease | Complement deficiency disease | 1.06e-03 | 33 | 43 | 2 | C0272242 | |
| Disease | sporadic amyotrophic lateral sclerosis | 1.12e-03 | 140 | 43 | 3 | EFO_0001357 | |
| Disease | ascending aortic diameter | 1.12e-03 | 140 | 43 | 3 | EFO_0021787 | |
| Disease | complement factor H-related protein 3 measurement | 1.93e-03 | 169 | 43 | 3 | EFO_0600056 | |
| Disease | mean platelet volume | 3.44e-03 | 1020 | 43 | 6 | EFO_0004584 | |
| Disease | neutrophil count | 3.57e-03 | 1382 | 43 | 7 | EFO_0004833 | |
| Disease | SARS-CoV-2 antibody measurement, response to COVID-19 vaccine | 3.71e-03 | 62 | 43 | 2 | EFO_0803360, EFO_0803362 | |
| Disease | periodontitis | 4.21e-03 | 223 | 43 | 3 | EFO_0000649 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NGSWSSEGCELTYSN | 381 | Q9HBW9 | |
| ASNQSKGTSAYCSAW | 206 | Q8WYN0 | |
| KWTCSNGNSSSGFSV | 226 | Q9Y6Y1 | |
| AQAWQQGSCASLGTS | 161 | A0A096LP49 | |
| DSYGTSNNCWLSLAS | 696 | Q6QNK2 | |
| SDACNTTGSGFWNSS | 1041 | Q9H7F0 | |
| GFCWAQYSSNTQQGR | 11 | P0DTE7 | |
| GFCWAQYSSNTQQGR | 11 | P0DTE8 | |
| GFCWAQYSSNTQQGR | 11 | P0DUB6 | |
| TGNNGVFSWSSCSRQ | 466 | Q8TE60 | |
| TTCSFSANADSGNQW | 536 | Q96M43 | |
| AWGYNNCGQVGSGST | 151 | Q8NDN9 | |
| AGQTLAQSCWSAGST | 2641 | Q96L73 | |
| SYQAWRGVGSNAATS | 161 | Q9Y342 | |
| CSSAVGSWSYSQQQP | 741 | Q9Y5H6 | |
| SQYGTWTEQCQSGES | 1536 | Q9BY89 | |
| SNYGVSVLSNASGNW | 86 | O00180 | |
| CTGSSGSIASNYVQW | 41 | P01721 | |
| CSGSSSNIGSNYVYW | 41 | P01700 | |
| CSGSSSNIGNNYVSW | 41 | P01701 | |
| CSGSSSNIGSNTVNW | 41 | P01699 | |
| TSSLGTLGWSYQACT | 351 | P42785 | |
| SGVSNRCQSSYWTYG | 521 | P24043 | |
| TNGFTYGSSHQNWAS | 326 | Q5SRI9 | |
| TGSCNFETSSGNWTT | 1726 | Q5VYJ5 | |
| SSGSITCLQNGWSAQ | 186 | Q02985 | |
| QGSNYVTCSNGEWSE | 246 | Q02985 | |
| GSNGEQCWRQTYSES | 566 | Q8N960 | |
| GNSSGSITCLQNGWS | 126 | Q92496 | |
| NCSNLWGNFSYGSIC | 716 | P16109 | |
| LSESSNWGCYGNIQS | 16 | Q8N1E2 | |
| NNNTGIYTCSAQGVW | 406 | P48740 | |
| GWMGTSSLCNPYSNT | 1321 | Q8TEP8 | |
| GAQFWSASVSCQSQD | 136 | Q9H4B8 | |
| TPNSSWCNQTYSGSL | 306 | P60507 | |
| WCNQTYSGSLSNLSA | 311 | P60507 | |
| AGSYSCWVNNSIGQT | 566 | P20273 | |
| NSSSCELTGSGSWNN | 101 | Q9HC62 | |
| GRSQNCWGASNSNAG | 81 | Q9HCJ0 | |
| CGSQSIQWSFRSSNN | 1926 | A2VEC9 | |
| NNSYSGSNSGAAIGW | 371 | Q13148 | |
| SNGTDSTQTSGWQYD | 191 | Q8N3X1 | |
| STQTSGWQYDTQCSL | 196 | Q8N3X1 | |
| CSGSSSNIGNNAVNW | 41 | A0A0B4J1U3 | |
| TTCSFSANADSGNQW | 536 | Q5VWK0 | |
| LANNTGGWDSSGCYV | 961 | Q8IZF2 | |
| GAVQTACSWLQNYAS | 1336 | O75443 | |
| SYTDSTDGWSSINCG | 556 | O14924 | |
| CGSNSSADWQHSTYI | 156 | A1L157 | |
| FSAWGNNSSQGQSTQ | 131 | Q9Y5A9 | |
| ASNYANSTWGSGASS | 161 | Q9UPQ9 |